✦ LIBER ✦

Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis

✍ Scribed by Shu-zhen Wei; Ping Zhan; Mei-qi Shi; Yi Shi; Qian Qian; Li-ke Yu; Yong Song

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 338 KB
Volume: 28
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-010-9443-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ERCC1 and XPD/ERCC2 Polymorphisms’ Predi

ERCC1 and XPD/ERCC2 Polymorphisms’ Predictive Value of Oxaliplatin-Based Chemotherapies in Advanced Colorectal Cancer has an Ethnic Discrepancy: A Meta-analysis

✍ Xiaobo Lu; Sha Xiao; Cuihong Jin; Tahar van der Straaten; Xiaoxia Li 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

Our purpose is to evaluate the predictive value of the genetic polymorphisms of Excision repair cross-complementing group 1 (ERCC1) and xeroderma pigmentosum group D/excision repair crosscomplementing group 2 (XPD/ERCC2) in patients with advanced colorectal cancer receiving oxaliplatin-based chemoth

Positive expression of ERCC1 predicts a

Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer

✍ Xin Wang; Jun Zhao; Lu Yang; Li Mao; Tongtong An; Hua Bai; Shuhang Wang; Xuyi Li 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 271 KB

Cetuximab-based Therapy is Effective in

Cetuximab-based Therapy is Effective in Chemotherapy-naïve Patients with Advanced and Metastatic Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials

✍ Ezzeldin M. Ibrahim; Khaled M. Abouelkhair; Osama A. Al-Masri; Najeeb C. Chaudry 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 295 KB

Docetaxel and granulocyte colony-stimula

Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial

✍ K. Alexopoulos; C. Kouroussis; N. Androulakis; E. Papadakis; M. Vaslamatzis; S. 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 90 KB

Editorial comment on: “The development a

Editorial comment on: “The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced non-small cell lung cancer receiving palliative chemotherapy”. by Vincent et al.

✍ Wolfgang Korte 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 58 KB

Impact of angiotensin I converting enzym

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

✍ Stefan Wilop; Sabine von Hobe; Martina Crysandt; Albert Esser; Rainhardt Osieka; 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 319 KB